Abiraterone and increased survival in metastatic prostate cancer

JS De Bono, CJ Logothetis, A Molina… - … England Journal of …, 2011 - Mass Medical Soc
… both patients with progressing castration-resistant prostate cancerabiraterone acetate
and prednisone would improve overall survival among patients with advanced prostate cancer

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported …

E Basch, K Autio, CJ Ryan, P Mulders, N Shore… - … lancet oncology, 2013 - thelancet.com
Abiraterone acetate plus prednisone significantly … patients with metastatic castration-resistant
prostate cancer compared with prednisone alone. We describe analyses of data for patient-…

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind …

K Fizazi, HI Scher, A Molina, CJ Logothetis… - … lancet oncology, 2012 - thelancet.com
… This final analysis confirms that abiraterone acetate significantly prolongs overall survival
in patients with metastatic castration-resistant prostate cancer who have progressed after …

Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer

SM Hoy - Drugs, 2013 - Springer
… unless there is no therapeutic alternative in patients receiving abiraterone acetate [12, 13]. …
must be coadministered with abiraterone acetate, the abiraterone acetate dosage must be …

… following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer  …

KN Chi, A Protheroe, A Rodríguez-Antolín… - … Lancet Oncology, 2018 - thelancet.com
… Understanding the effects of treatments on patient-reported outcomes (PROs) and … plus
abiraterone acetate and prednisone versus ADT plus placebos on PROs and HRQOL in patients

Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

P Castellan, M Marchioni, R Castellucci… - … and clinical risk …, 2018 - Taylor & Francis
… of care for newly diagnosed, metastatic prostate cancer, first as a … More recently, the addition
of abiraterone acetate to ADT to … prostate cancer and metastatic hormone-sensitive prostate

Abiraterone acetate: a review in metastatic castration-resistant prostrate cancer

LJ Scott - Drugs, 2017 - Springer
… crucial in the progression from primary to metastatic prostate cancer (PC) and subsequently,
in the … In large phase 3 trials and in the clinical practice setting, oral abiraterone acetate in …

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two …

G Attard, L Murphy, NW Clarke, W Cross, RJ Jones… - The lancet, 2022 - thelancet.com
… There was no evidence of a difference in metatasis-free survival when enzalutamide and
abiraterone acetate were administered concurrently compared with abiraterone acetate alone (…

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival …

K Fizazi, NP Tran, L Fein, N Matsubara… - … Lancet Oncology, 2019 - thelancet.com
… study, the addition of abiraterone acetate plus prednisone to androgen … prostate cancer
(mCSPC). Here, we present long-term survival outcomes and safety of abiraterone acetate plus …

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration …

CJ Logothetis, E Basch, A Molina, K Fizazi… - … lancet oncology, 2012 - thelancet.com
… To establish whether CYP17 inhibition with abiraterone acetate can improve pain and …
prostate cancer after treatment with docetaxel, we prospectively measured and analysed patient-…